UNICK FIX-A-FORM AND PRINTERS | EARUM PHARMACEUTICALS | UNICK FIX-A-FORM AND PRINTERS/ EARUM PHARMACEUTICALS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.9 | -47.2 | - | View Chart |
P/BV | x | 1.1 | 2.2 | 53.3% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
UNICK FIX-A-FORM AND PRINTERS EARUM PHARMACEUTICALS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
EARUM PHARMACEUTICALS Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ EARUM PHARMACEUTICALS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 8 | 711.4% | |
Low | Rs | 32 | 2 | 1,623.7% | |
Sales per share (Unadj.) | Rs | 120.5 | 2.3 | 5,275.2% | |
Earnings per share (Unadj.) | Rs | 4.1 | 0.3 | 1,271.0% | |
Cash flow per share (Unadj.) | Rs | 11.2 | 0.3 | 3,318.8% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 53.9 | 3.0 | 1,777.3% | |
Shares outstanding (eoy) | m | 5.49 | 61.68 | 8.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 2.2 | 16.7% | |
Avg P/E ratio | x | 11.1 | 15.9 | 69.5% | |
P/CF ratio (eoy) | x | 4.0 | 15.1 | 26.6% | |
Price / Book Value ratio | x | 0.8 | 1.7 | 49.7% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 248 | 316 | 78.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 1 | 11,823.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 141 | 469.5% | |
Other income | Rs m | 5 | 23 | 22.6% | |
Total revenues | Rs m | 667 | 164 | 407.7% | |
Gross profit | Rs m | 88 | 9 | 946.7% | |
Depreciation | Rs m | 39 | 1 | 3,766.3% | |
Interest | Rs m | 24 | 3 | 821.4% | |
Profit before tax | Rs m | 30 | 28 | 106.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 8 | 91.8% | |
Profit after tax | Rs m | 22 | 20 | 113.1% | |
Gross profit margin | % | 13.3 | 6.6 | 201.6% | |
Effective tax rate | % | 25.0 | 29.1 | 85.8% | |
Net profit margin | % | 3.4 | 14.1 | 24.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 281 | 107.1% | |
Current liabilities | Rs m | 287 | 99 | 290.8% | |
Net working cap to sales | % | 2.1 | 129.4 | 1.6% | |
Current ratio | x | 1.0 | 2.8 | 36.8% | |
Inventory Days | Days | 4 | 0 | - | |
Debtors Days | Days | 72,349,839 | 2,173 | 3,329,515.3% | |
Net fixed assets | Rs m | 402 | 5 | 8,420.3% | |
Share capital | Rs m | 55 | 123 | 44.5% | |
"Free" reserves | Rs m | 241 | 64 | 378.4% | |
Net worth | Rs m | 296 | 187 | 158.2% | |
Long term debt | Rs m | 89 | 0 | - | |
Total assets | Rs m | 705 | 286 | 246.8% | |
Interest coverage | x | 2.3 | 10.6 | 21.2% | |
Debt to equity ratio | x | 0.3 | 0 | - | |
Sales to assets ratio | x | 0.9 | 0.5 | 190.3% | |
Return on assets | % | 6.6 | 7.9 | 82.5% | |
Return on equity | % | 7.6 | 10.6 | 71.5% | |
Return on capital | % | 14.0 | 16.5 | 84.6% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 3 | 1,660.8% | |
From Investments | Rs m | -27 | NA | - | |
From Financial Activity | Rs m | -16 | -3 | 562.1% | |
Net Cashflow | Rs m | 0 | 0 | -125.0% |
Indian Promoters | % | 71.6 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 100.0 | 28.4% | |
Shareholders | 1,622 | 58,634 | 2.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | EARUM PHARMACEUTICALS | S&P BSE TECK |
---|---|---|---|
1-Day | 4.56% | -1.81% | -0.26% |
1-Month | 21.23% | 3.82% | -0.74% |
1-Year | 56.84% | -25.57% | 29.95% |
3-Year CAGR | 31.01% | -36.74% | 10.57% |
5-Year CAGR | 20.58% | -14.68% | 15.11% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the EARUM PHARMACEUTICALS share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of EARUM PHARMACEUTICALS the stake stands at 0.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of EARUM PHARMACEUTICALS.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
EARUM PHARMACEUTICALS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of EARUM PHARMACEUTICALS.
For a sector overview, read our media sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.